Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2990|44|1|6-17

ISSN： 0305-1846

Source： NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol.44, Iss.1, 2018-02, pp. : 6-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 4, 2015-04 ,pp. : 720-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia

By  

EPILEPSIA, Vol. 56, Iss. 4, 2015-04 ,pp. : 636-646

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphorylation of the ribosomal protein S6, a marker of mTOR (mammalian target of rapamycin) pathway activation, is strongly increased in hypertrophic scars and keloids

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1415-1417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 3, 2015-09 ,pp. : 375-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 4, 2015-04 ,pp. : 675-683

John Wiley & Sons Inc

Access to resources Recommend Favorite